Autolus Therapeutics Ltd (AUTL) — Working Capital to Net Assets Ratio
Autolus Therapeutics Ltd (AUTL) has a Working Capital to Net Assets ratio of 280.5% as of March 2026. Working capital of $305.24 Million (current assets of $368.83 Million minus current liabilities of $63.60 Million) is measured against net assets of $108.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Autolus Therapeutics Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Autolus Therapeutics Ltd Working Capital to Net Assets (2015–2025)
This chart shows how Autolus Therapeutics Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 280.5%, reflecting working capital of $305.24 Million against net assets of $108.83 Million USD. See Autolus Therapeutics Ltd (AUTL) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Autolus Therapeutics Ltd (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Autolus Therapeutics Ltd from 2015 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Autolus Therapeutics Ltd.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 203.5% | $362.48 Million | $178.13 Million | $435.92 Million | $73.44 Million | ▲ +63.0 pp |
| 2024 | 140.5% | $600.19 Million | $427.32 Million | $660.93 Million | $60.74 Million | ▼ -66.4 pp |
| 2023 | 206.8% | $230.56 Million | $111.47 Million | $275.30 Million | $44.74 Million | ▲ +79.8 pp |
| 2022 | 127.0% | $379.40 Million | $298.67 Million | $425.77 Million | $46.37 Million | ▲ +25.4 pp |
| 2021 | 101.6% | $318.40 Million | $313.32 Million | $346.95 Million | $28.55 Million | ▲ +25.3 pp |
| 2020 | 76.3% | $160.34 Million | $210.03 Million | $193.98 Million | $33.63 Million | ▼ -11.7 pp |
| 2019 | 88.0% | $224.27 Million | $254.84 Million | $249.26 Million | $24.98 Million | ▼ -3.0 pp |
| 2018 | 91.0% | $186.63 Million | $205.14 Million | $199.14 Million | $12.52 Million | ▲ +0.0 pp |
| 2018 | 91.0% | $186.63 Million | $205.14 Million | $199.14 Million | $12.52 Million | ▼ -5.4 pp |
| 2017 | 96.4% | $137.45 Million | $142.60 Million | $142.48 Million | $5.03 Million | ▲ +4.5 pp |
| 2016 | 91.9% | $28.19 Million | $30.69 Million | $30.93 Million | $2.73 Million | ▲ +45.8 pp |
| 2015 | 46.1% | $9.55 Million | $20.71 Million | $11.49 Million | $1.95 Million | — |